Gina Keiffer, MD
Assistant Professor
Contact
Honickman Center
1101 Chestnut Street
14th Floor
Philadelphia, PA 19107
Gina Keiffer, MD
Assistant Professor
Research & Clinical Interests
As an assistant professor in the Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation at Thomas Jefferson University, I am focused on building a career dedicated to the advancement of care of patients with myeloid malignancies, particularly AML and MDS. My specific research interest is in early-phase clinical trials utilizing novel targeted agents and on novel combinations with conventional chemotherapy. I have designed and initiated investigator initiated clinical trials in conjunction with collaborating laboratory colleagues where I serve as PI and seek to improve patient management and further the mechanistic understanding of novel agents and therapy resistance mechanisms in AML and MDS. I also serve as PI on industry sponsored and cooperative group clinical trials. To gain essential skills in clinical trial design and implementation, I am pursuing formalized training in clinical trial design, epidemiology, biostatistical methods and research ethics through a Master’s degree in Human Investigation through the Jefferson College of Biomedical sciences.
Education
Medical School
Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, 2013
Residency
Thomas Jefferson University Hospital, Philadelphia, PA, 2016
Chief Medical Residency, Thomas Jefferson University Hospital, Philadelphia, PA, 2017
Fellowship
Hematology and Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA, 2020
Publications
- Treatment of Acute Myeloid Leukemia in the Community Setting
- A phase I study of the combination of palbociclib and dexamethasone for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia
- A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation
- Debating Frontline Therapy in Chronic Myeloid Leukemia
- Inpatient versus outpatient hypomethylating agent induction for acute myeloid leukemia as a predictor for survival
Certifications
- American Board of Internal Medicine, Internal Medicine
- American Board of Internal Medicine, Hematology
- American Board of Internal Medicine, Medical Oncology
Awards
PA-CURE Grant, 2023
Arnold Weitz Memorial Prize for Aptitude and Interest in Hematology